Alvotech ALVO
NASDAQ ALVO
$5.21 +0.02 (+0.38%)
As of: Sep 9, 2026 · 3:59 PM EDT

Alvotech (ALVO) Receivables - Other (2020 - 2026)

Alvotech's (ALVO) quarterly Receivables - Other came in at $165.0 million in Q2 2026, up 414.52% on a YoY basis from $32.1 million in Q2 2025, and up 26.9% quarter-over-quarter from $130.0 million in Q1 2026.

Analysis

Alvotech (ALVO) Receivables - Other (2020 - 2026) Analysis & Trends

Alvotech (ALVO) has reported Receivables - Other for 7 consecutive years, with $165.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Receivables - Other rose 414.52% year-over-year to $165.0 million; the trailing twelve-month figure through Jun 2026 stood at $165.0 million (up 414.52% YoY), and the FY2025 full-year result was $122.9 million, up 441.32% from the prior year.
  • Receivables - Other improved to $165.0 million in Q2 2026 per ALVO's latest filing, from $130.0 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $165.0 million in Q2 2026 and bottomed at $3.3 million in Q4 2022.
  • Historically, Receivables - Other has averaged $47.4 million across 5 years, with a median of $25.8 million in 2024.
  • The sharpest annual moves came in 2023 and 2026: Receivables - Other slumped 43.98% in 2023, then soared 472.58% in 2026.
  • Over 5 years, Receivables - Other stood at $3.3 million in 2022, then jumped by 230.37% to $10.9 million in 2023, then soared by 109.19% to $22.7 million in 2024, then soared by 441.32% to $122.9 million in 2025, then jumped by 34.22% to $165.0 million in 2026.
  • According to Business Quant data, Receivables - Other over the past three periods registered $165.0 million, $130.0 million, and $122.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 165.01 Mn
Mar 31, 2026 130.03 Mn
Dec 31, 2025 122.93 Mn
Sep 30, 2025 58.70 Mn
Jun 30, 2025 32.07 Mn
Mar 31, 2025 22.71 Mn
Dec 31, 2024 22.71 Mn
Sep 30, 2024 28.83 Mn
Jun 30, 2024 33.46 Mn
Mar 31, 2024 10.36 Mn
Dec 31, 2023 10.86 Mn
Jun 30, 2023 8.31 Mn
Dec 31, 2022 3.29 Mn
Jun 30, 2022 14.84 Mn
Dec 31, 2021 1.48 Mn
Dec 31, 2020 2.19 Mn